The main department of described VC is located in the London. The fund was located in Europe if to be more exact in United Kingdom.
The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2017. The important activity for fund was in 2009. This Solon Ventures works on 31 percentage points more the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Solon Ventures, startups are often financed by Ventech, Quest for Growth, Gilde Healthcare. The meaningful sponsors for the fund in investment in the same round are Ventech, Quest for Growth, Gilde Healthcare. In the next rounds fund is usually obtained by Accel, 14W, Ventech.
The fund was created by Angus Whiteley, Richard Thompson.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight Concentra, Fever, Nimbus Partners. We can highlight the next thriving fund investment areas, such as Online Games, Biotechnology.
Related Funds
Funds with similar focus
Fund Name | Location |
BDB Ventures | New York, New York, United States |
Bighorn Ventures | - |
Blue Ivy Ventures | Boston, Massachusetts, United States |
Brobeck, Phleger & Harrison | - |
Capital Fortune | Beijing, Beijing, China |
Cox Enterprises Social Impact Accelerator powered by Techstars | Atlanta, Georgia, United States |
CREATE Partners | Cambridge, Cambridgeshire, United Kingdom |
GDA Group | - |
ICF Group | - |
Levant Capital Limited | Dubai, United Arab Emirates |
NRMA | Australia, New South Wales, Sydney |
Portuguese Mint and Official Printing Office (INCM) | Lisboa, Lisbon, Portugal |
Reus Capital Partners | Barcelona, Catalonia, Spain |
SMC Capital China | China, Shanghai |
The Rise Fund | California, San Francisco, United States |
Trinity Capital Investment | Arizona, Phoenix, United States |
Watson-Marlow | Massachusetts, United States, Wilmington |
Wedbush Securities | California, Los Angeles, United States |
Yokohama Capital | Japan, Kanagawa Prefecture, Yokohama |
Your Voice SPA | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Fever | $1M | 07 May 2014 | New York, New York, United States | ||
Prosonix | $23M | 24 May 2012 | England | ||
Prosonix | $15M | 06 Jul 2011 | England | ||
Novalia | 08 Mar 2007 | Cambridge, England, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Fever | $1M | 07 May 2014 | New York, New York, United States | ||
Prosonix | $23M | 24 May 2012 | England | ||
Prosonix | $15M | 06 Jul 2011 | England | ||
Novalia | 08 Mar 2007 | Cambridge, England, United Kingdom |